Orange Medipharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Lucknow, Uttar Pradesh, India, established in 2015.
2015 Lucknow, Uttar Pradesh, India Active
Last Updated:
Access Report
About Orange Medipharmaceuticals Private Limited

Orange Medipharmaceuticals Private Limited, a active private limited company, was established on 05 November 2015 in Lucknow, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24233UP2015PTC074326. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.24 M.

It upholds a compliant status. Its leadership includes Imran Ahmad Ansari (Director), Humera Yaseen (Director), Abdullah Saleh Salmen Anooz Al Ameri (Director). Past directors included Abdullah Saleh Salmen Anooz Al Ameri. It holds ₹4.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No. 631/168-A, Rajeev Nagar Ismail Ganj, Ward-Ii, Lucknow, Uttar Pradesh, 226016.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233UP2015PTC074326

  • Registration Number

    074326

  • Incorporation Date

    05 November 2015

  • Authorized Capital

    ₹2.50 M

  • Paid-Up Capital

    ₹2.24 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 2.24 M
  • Company Age 10 Year, 3 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 4.00 M
  • Revenue Growth **** -38.68%
  • Profit Growth **** 9143.84%
  • Ebitda **** 173.16%
  • Net Worth -14.58%
  • Total Assets **** 55.30%
Company report

Orange Medipharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Orange Medipharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Orange Medipharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Imran Ahmad Ansari Director 05 Nov 2015 Current
Humera Yaseen Director 05 Nov 2015 Current
Abdullah Saleh Salmen Anooz Al Ameri Director 17 May 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Orange Medipharmaceuticals.

Orange Medipharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 38.68% decrease. The company also saw a substantial improvement in profitability, with a 9143.84% increase in profit. The company's net worth observed a substantial decline by a decrease of 14.58%.

Orange Medipharmaceuticals revenue growth over time
Orange Medipharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -38.68%
*******
*******
*******
*******
Revenue from Operations
*******
 -40.04%
*******
*******
*******
*******
Total Assets
*******
 55.30%
*******
*******
*******
*******
Profit or Loss
*******
 9143.84%
*******
*******
*******
*******
Net Worth
*******
 -14.58%
*******
*******
*******
*******
EBITDA
*******
 173.16%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Orange Medipharmaceuticals?

In 2020, Orange Medipharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹4,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 0.40 Cr
Latest Charge Details
Date Lender Amount Status
23 Jun 2021 Others ₹4.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Orange Medipharmaceuticals?

Unlock and access historical data on people associated with Orange Medipharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Orange Medipharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orange Medipharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Orange Medipharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Orange Medipharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Orange Medipharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was recorded as a recent event.

  • Charges

    A charge with Others amounted to Rs. 4.00 M with Charge ID 100455254 was registered on 23 Jun 2021. was recorded as a recent event.

  • Director Appointment

    Abdullah Saleh Salmen Anooz Al Ameri was appointed as a Director was appointed as a Director on 17 May 2017 & has been associated with this company since 8 years 8 months . was recorded as a recent event.

  • Director Appointment

    Imran Ahmad Ansari was appointed as a Director was appointed as a Director on 05 Nov 2015 & has been associated with this company since 10 years 3 months . was recorded as a recent event.

  • Director Appointment

    Progress on Humera Yaseen was appointed as a Director was appointed as a Director on 05 Nov 2015 & has been associated with this company since 10 years 3 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Orange Medipharmaceuticals Private Limited?

The CIN of Orange Medipharmaceuticals Private Limited is U24233UP2015PTC074326.

Where is Orange Medipharmaceuticals Private Limited headquartered?

Orange Medipharmaceuticals Private Limited is headquartered at H.No. 631/168-A, Rajeev Nagar Ismail Ganj, Ward-Ii, Lucknow, Uttar Pradesh, 226016.

When was Orange Medipharmaceuticals Private Limited incorporated?

Orange Medipharmaceuticals Private Limited was incorporated on 05 November 2015.

Who are the current directors of Orange Medipharmaceuticals Private Limited?

The current directors of Orange Medipharmaceuticals Private Limited are

What is the primary industry of Orange Medipharmaceuticals Private Limited?

The primary industry of Orange Medipharmaceuticals Private Limited is Trade.

Is Orange Medipharmaceuticals Private Limited a listed company?

Orange Medipharmaceuticals Private Limited is unlisted.

What is the capital structure of Orange Medipharmaceuticals Private Limited?

The authorized capital of Orange Medipharmaceuticals Private Limited is ₹2.50 M, and the paid-up capital is ₹2.24 M.

What is the compliance status of Orange Medipharmaceuticals Private Limited?

The compliance status of Orange Medipharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available